273 related articles for article (PubMed ID: 32519351)
1. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
[TBL] [Abstract][Full Text] [Related]
2. [Richter Syndrome: Diagnostic and Therapeutic Management].
Croizier C; Guièze R
Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
[TBL] [Abstract][Full Text] [Related]
4. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
5. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.
Mauro FR; Chauvie S; Paoloni F; Biggi A; Cimino G; Rago A; Gentile M; Morabito F; Coscia M; Bellò M; Sacchetti GM; Rossi D; Laurenti L; Autore F; Campanelli M; Trastulli F; Nicolai E; Riminucci M; Gaidano G; Guarini A; Gallamini A; Foà R
Leukemia; 2015 Jun; 29(6):1360-5. PubMed ID: 25650091
[TBL] [Abstract][Full Text] [Related]
8. Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Bouclet F; Calleja A; Dilhuydy MS; Véronèse L; Pereira B; Amorim S; Cymbalista F; Herbaux C; de Guibert S; Roos-Weil D; Hivert B; Aurran T; Dupuis J; Blouet A; Tchernonog E; Laribi K; Dmytruck N; Morel P; Michallet AS; Dartigeas C; Tournilhac O; Nguyen-Khac F; Delmer A; Feugier P; Ysebaert L; Guièze R
Ann Hematol; 2021 Apr; 100(4):987-993. PubMed ID: 33495922
[TBL] [Abstract][Full Text] [Related]
9. Richter Syndrome.
Condoluci A; Rossi D
Curr Oncol Rep; 2021 Feb; 23(3):26. PubMed ID: 33580422
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
Parikh SA; Rabe KG; Call TG; Zent CS; Habermann TM; Ding W; Leis JF; Schwager SM; Hanson CA; Macon WR; Kay NE; Slager SL; Shanafelt TD
Br J Haematol; 2013 Sep; 162(6):774-82. PubMed ID: 23841899
[TBL] [Abstract][Full Text] [Related]
11. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
[TBL] [Abstract][Full Text] [Related]
12. Biology and treatment of Richter syndrome.
Rossi D; Spina V; Gaidano G
Blood; 2018 Jun; 131(25):2761-2772. PubMed ID: 29692342
[TBL] [Abstract][Full Text] [Related]
13. How we treat Richter syndrome.
Parikh SA; Kay NE; Shanafelt TD
Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
[TBL] [Abstract][Full Text] [Related]
14. Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia.
Fan L; Wang L; Zhang R; Fang C; Zhu DX; Wang YH; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2012 Sep; 53(9):1749-56. PubMed ID: 22329349
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
[TBL] [Abstract][Full Text] [Related]
16. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
[TBL] [Abstract][Full Text] [Related]
17. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
18. Richter syndrome: molecular insights and clinical perspectives.
Rossi D; Gaidano G
Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
[TBL] [Abstract][Full Text] [Related]
20. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
